Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Janice Rafferty

Colon & Rectal Surgery Cincinnati, OH Medical Doctor

NPI 1871561464 CMS profile 701935

2123 Auburn Ave, Ste. 524, Cincinnati, OH 45219

Open in the dashboard

General payments

$164,251

138 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Janice Rafferty of Cincinnati, OH is reported in the CMS Open Payments database as having received $164,251 across 138 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Colon & Rectal Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $2,225 5
2024 General $17,604 24
2023 General $23,763 27
2022 General $17,962 25
2021 General $22,428 11
2020 General $13,287 10
2019 General $66,983 36

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Janice Rafferty
  • Colon & Rectal Surgery median
  • Middle half of Colon & Rectal Surgery
  • National median

In program year 2025, general payments to Janice Rafferty were reported at $2,225. Among 1,481 Colon & Rectal Surgery profiles paid that year, the median was $317 and the middle half received between $109 and $1,248.

Show as a table
Year Janice Rafferty Colon & Rectal Surgery median Middle half National median
2019 $66,983 $443 $125–$2,179 $163
2020 $13,287 $167 $53–$931 $114
2021 $22,428 $207 $72–$1,272 $132
2022 $17,962 $341 $111–$1,587 $149
2023 $23,763 $322 $115–$1,420 $160
2024 $17,604 $328 $112–$1,354 $164
2025 $2,225 $317 $109–$1,248 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Stryker Corporation $141,533 87 payments
  2. Allergan Inc. $13,107 13 payments
  3. Intuitive Surgical, Inc. $7,512 34 payments
  4. Ethicon Inc. $2,020 1 payment
  5. Exelixis Inc. $46 1 payment
  6. Merck Sharp & Dohme Corporation $18 1 payment
  7. Mallinckrodt Enterprises LLC $14 1 payment

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $138,193 41 payments
  2. Travel and Lodging $21,013 47 payments
  3. Food and Beverage $4,462 45 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $500 1 payment
  5. Gift $64 3 payments
  6. Education $18 1 payment
Products named General payments · program years 2019–2025
  1. SPY-PHI SYSTEM $44,478 30 payments
  2. SPY TECHNOLOGY $33,435 16 payments
  3. 1688 HD 3 CHIP CAMERA $30,312 8 payments
  4. 1588 HD 3 CHIP CAMERA $23,629 6 payments
  5. DERMACELL $23,562 5 payments
  6. 1688 $18,890 8 payments
  7. 1788 $14,036 19 payments
  8. STRATTICE $13,107 13 payments
  9. Da Vinci Surgical System $6,642 32 payments
  10. ENSEAL Product Family $2,020 1 payment
  11. Other $9,339 16 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 3 drugs

Part D claims

46

Median for Colorectal Surgery (Proctology): 106

Drug cost

$1,037

Median for Colorectal Surgery (Proctology): $1,614

Branded share of claims

23.9%

Median for Colorectal Surgery (Proctology): 35.9%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Diphenoxylate-Atropine Diphenoxylate Hcl/Atropine Brand 11 $707
Metronidazole Generic 18 $221
Ciprofloxacin Hcl Generic 17 $108

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,507 Part D prescribers listed as Colorectal Surgery (Proctology); they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 51 billing codes

Paid by Medicare

$67,303

Medicare's payments for the services billed

Medicare patients

162

Average age 74

Services billed

347

117 women, 45 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 73%
Arthritis 53%
Cancer 38%
Ischemic heart disease 35%
Diabetes 26%
Chronic kidney disease 24%
Depression 22%
Osteoporosis 20%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

138 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Colon & Rectal Surgery in Ohio

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record